Hepatitis C diagnostics: Clinical evaluation of the HCV-core antigen determination;Hepatitis-C-diagnostik: Klinische evaluierung der hcv-core-antigenbestimmung

Zeitschrift fur Gastroenterologie

Volumn 52, Issue 10, 2014, Pages 1164-1170

  Van Helden, Josef ^a   Weiskirchen, R ^b  

^a MVZ Dr Stein und Kollegen   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

diagnostic window; HCV core antigen; hepatitis C; sensitivity; specificity

Indexed keywords

HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA; BIOLOGICAL MARKER; CORE PROTEIN;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL EVALUATION; CORRELATION ANALYSIS; EARLY DIAGNOSIS; HEPATITIS C; HUMAN; IMMUNOASSAY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; ADULT; BLOOD; COMPARATIVE STUDY; FEMALE; GENETICS; IMMUNOLOGY; MALE; MIDDLE AGED; REPRODUCIBILITY; VIROLOGY; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS; YOUNG ADULT;

EID: 84929359253     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0034-1366618     Document Type: Article

References (18)

1. Poethko-Müller C., Zimmermann R., Homouda O. et al. Epidemiology of hepatitis A, B and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt: 2013; 56 707 715
2. Robert Koch Institut: Epidemiologisches Bulletin 30/2013.
3. Robert Koch Institut: Epidemiologisches Bulletin 46/2005.
4. Armstrong G. L., Wasley A., Simard E. P. et al. The prevalence of hepatitis C virus infection in the United States. Annals Int Med: 2006; 144 705 714
5. Mutimer D., Aghemo A., Diepolder H. et al. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol: 2014; 60 392 420
6. Detering K., Grüner N., Buggisch P. et al. Delayed versus immediate treatment for patients with acute hepatitis C: a randomized controlled non inferiority trial. Lancet Infect. Diseas: 2013; 13 497 506
7. Laperche S., Elghouzzi M. H., Morel P. et al. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion: 2005; 45 1965 1972
8. Hayashi K., Hasuike S., Kusumoto K. et al. Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population. J Viral Hepatitis: 2005; 12 106 110
9. Maynard M., Pradat P., Berthillon P. et al. Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepatitis: 2003; 10 318 323
10. Gonzales V., Padilla E., Diago M. et al. Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin. J Viral Hepatitis: 2005; 12 481 487
11. NCCLS Document EP5A. Evaluation of precision performance of clinical chemistry devices. Approved guidline. 1999; 2nd ed
12. Ross R. S., Viazov S., Salloum S. et al. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. JCM: 2010; 48 04 1161 1168
13. Dati F., Denoyel G., van Helden J. European performance evaluations of the ADVIA Centaur® infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. J Clin Virol: 2004; 30 5 9
14. Mederacke I., Wedemeyer H., Ciesek S. et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol: 2009; 46 210 221
15. Morota K., Fujinami R., Kinikawa H. et al. A new sensitive and automated chemiluninescent microparticle immunoassay for the quantitative determination of hepatitis C core antigen. J Virol Method: 2009; 157 8 14
16. Esteban J. I., van Helden J., Alborino F. et al. Multicenter Evaluation of the Elecsys® Anti-HCV II Assay for the Diagnosis of Hepatitis C Virus Infection: J. Med. Virol: 2013; 85 1362 1368
17. Midouge M., Saune K., Kamar N. et al. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 48: 2010; 48 18 21
18. Seger G. Drogen und Hepatitis C: Neue Konzepte der Prävention gesucht. DÄ 2004; 101 1929